Improved Outcomes after Lower Limb Revascularization

Operator ability combined with improved and diverse devices for lower limb revascularization has clearly increased in the last decade. However, is this technical feasibility we did not use to have translating into better clinical outcomes for patients, or is it simply inflating our interventionist egos?

Mejorando los resultados luego de la revascularización de miembros inferiores

This study aims at answering the question above by identifying an astonishing 103934 patient population undergoing endovascular (endarterectomy) or surgical (profundaplasty or bypass) lower limb revascularization for infrainguinal peripheral artery disease between 2006 and 2015.

Major amputation and deaths within a year after procedure were registered and adjusted by age, sex, diabetes and other comorbidities, in addition to revascularization indication (Intermittent claudication, severe ischemia with tissue loss, severe ischemia with gangrene/osteomyelitis).

The risk of major amputation at one year after endovascular procedure dropped from 5.7% (2006-2007) to 3.9% (2014-2015). For surgical revascularization, risk dropped from 11.2% (2006-2007) to 6.6% (2014-2015).


Read also: Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery.


Mortality risk after both revisualization types also dropped over time. These trends were observed in all the clinical spectrum that justified revascularization indication, though the biggest benefit was in patients with severe ischemia and tissue loss or gangrene.

A curiosity observed over the years is increased morbidity, which could easily be explained by a larger proportion of patients treated at the end of their disease (sever ischemia with tissue los or gangrene) by less invasive methods.

Conclusion

These ten-year findings show an increase of survival rate and a reduction in major amputation after revascularization procedures. Outcomes have effectively improved hand in hand with experience and new devices, which justifies centralization and specialization of peripheral vascular centers.

Original Title: Improving 1-year Outcomes of Infrainguinal Limb Revascularisation: A Population-Based Cohort Study of 104 000 Patients in England.

Reference: Heikkila et al. Circulation. 2018 May 1;137(18):1921-1933.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...